UniProt ID | SPCS2_HUMAN | |
---|---|---|
UniProt AC | Q15005 | |
Protein Name | Signal peptidase complex subunit 2 | |
Gene Name | SPCS2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 226 | |
Subcellular Localization |
Microsome membrane Multi-pass membrane protein. Endoplasmic reticulum membrane Multi-pass membrane protein. |
|
Protein Description | Component of the microsomal signal peptidase complex which removes signal peptides from nascent proteins as they are translocated into the lumen of the endoplasmic reticulum.. | |
Protein Sequence | MAAAAVQGGRSGGSGGCSGAGGASNCGTGSGRSGLLDKWKIDDKPVKIDKWDGSAVKNSLDDSAKKVLLEKYKYVENFGLIDGRLTICTISCFFAIVALIWDYMHPFPESKPVLALCVISYFVMMGILTIYTSYKEKSIFLVAHRKDPTGMDPDDIWQLSSSLKRFDDKYTLKLTFISGRTKQQREAEFTKSIAKFFDHSGTLVMDAYEPEISRLHDSLAIERKIK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAAAVQGG ------CCCCCCCCC | 13.05 | 25944712 | |
11 | Phosphorylation | AAVQGGRSGGSGGCS CCCCCCCCCCCCCCC | 51.27 | 25159151 | |
14 | Phosphorylation | QGGRSGGSGGCSGAG CCCCCCCCCCCCCCC | 35.22 | 25159151 | |
18 | Phosphorylation | SGGSGGCSGAGGASN CCCCCCCCCCCCCCC | 34.65 | 28450419 | |
24 | Phosphorylation | CSGAGGASNCGTGSG CCCCCCCCCCCCCCC | 35.61 | 28450419 | |
28 | Phosphorylation | GGASNCGTGSGRSGL CCCCCCCCCCCCCCC | 30.30 | 28450419 | |
30 | Phosphorylation | ASNCGTGSGRSGLLD CCCCCCCCCCCCCCC | 30.76 | 26074081 | |
33 | Phosphorylation | CGTGSGRSGLLDKWK CCCCCCCCCCCCCCC | 37.00 | 26074081 | |
38 | Ubiquitination | GRSGLLDKWKIDDKP CCCCCCCCCCCCCCC | 50.81 | 33845483 | |
38 | Acetylation | GRSGLLDKWKIDDKP CCCCCCCCCCCCCCC | 50.81 | 25953088 | |
40 | Ubiquitination | SGLLDKWKIDDKPVK CCCCCCCCCCCCCEE | 41.83 | 29967540 | |
44 | 2-Hydroxyisobutyrylation | DKWKIDDKPVKIDKW CCCCCCCCCEEEEEC | 48.22 | - | |
47 | Ubiquitination | KIDDKPVKIDKWDGS CCCCCCEEEEECCCH | 54.43 | 29967540 | |
50 | 2-Hydroxyisobutyrylation | DKPVKIDKWDGSAVK CCCEEEEECCCHHHH | 51.13 | - | |
50 | Ubiquitination | DKPVKIDKWDGSAVK CCCEEEEECCCHHHH | 51.13 | 29967540 | |
54 | Phosphorylation | KIDKWDGSAVKNSLD EEEECCCHHHHHHCC | 27.67 | 21815630 | |
57 | Ubiquitination | KWDGSAVKNSLDDSA ECCCHHHHHHCCHHH | 40.30 | 21906983 | |
66 | Ubiquitination | SLDDSAKKVLLEKYK HCCHHHHHHHHHHHH | 37.52 | - | |
71 | 2-Hydroxyisobutyrylation | AKKVLLEKYKYVENF HHHHHHHHHHHHHHC | 47.19 | - | |
71 | Acetylation | AKKVLLEKYKYVENF HHHHHHHHHHHHHHC | 47.19 | 25825284 | |
71 | Ubiquitination | AKKVLLEKYKYVENF HHHHHHHHHHHHHHC | 47.19 | 29967540 | |
71 | Malonylation | AKKVLLEKYKYVENF HHHHHHHHHHHHHHC | 47.19 | 26320211 | |
73 | Acetylation | KVLLEKYKYVENFGL HHHHHHHHHHHHCCC | 54.62 | 26051181 | |
137 | Ubiquitination | IYTSYKEKSIFLVAH HHHHCCCCEEEEEEE | 44.70 | 33845483 | |
138 | Phosphorylation | YTSYKEKSIFLVAHR HHHCCCCEEEEEEEC | 21.47 | 21406692 | |
146 | Ubiquitination | IFLVAHRKDPTGMDP EEEEEECCCCCCCCH | 59.18 | 29967540 | |
149 | Phosphorylation | VAHRKDPTGMDPDDI EEECCCCCCCCHHHH | 56.10 | 20068231 | |
160 | Phosphorylation | PDDIWQLSSSLKRFD HHHHHHHHHHHCCCC | 11.63 | 30108239 | |
161 | Phosphorylation | DDIWQLSSSLKRFDD HHHHHHHHHHCCCCC | 48.56 | 30108239 | |
162 | Phosphorylation | DIWQLSSSLKRFDDK HHHHHHHHHCCCCCC | 34.24 | 30108239 | |
164 | 2-Hydroxyisobutyrylation | WQLSSSLKRFDDKYT HHHHHHHCCCCCCEE | 53.63 | - | |
164 | Ubiquitination | WQLSSSLKRFDDKYT HHHHHHHCCCCCCEE | 53.63 | 21906983 | |
169 | 2-Hydroxyisobutyrylation | SLKRFDDKYTLKLTF HHCCCCCCEEEEEEE | 41.81 | - | |
169 | Ubiquitination | SLKRFDDKYTLKLTF HHCCCCCCEEEEEEE | 41.81 | 22817900 | |
169 | Acetylation | SLKRFDDKYTLKLTF HHCCCCCCEEEEEEE | 41.81 | 19608861 | |
169 | Malonylation | SLKRFDDKYTLKLTF HHCCCCCCEEEEEEE | 41.81 | 26320211 | |
175 | Phosphorylation | DKYTLKLTFISGRTK CCEEEEEEEEECCCH | 19.82 | 23312004 | |
178 | Phosphorylation | TLKLTFISGRTKQQR EEEEEEEECCCHHHH | 20.31 | 24719451 | |
191 | 2-Hydroxyisobutyrylation | QREAEFTKSIAKFFD HHHHHHHHHHHHHHC | 45.23 | - | |
191 | Malonylation | QREAEFTKSIAKFFD HHHHHHHHHHHHHHC | 45.23 | 26320211 | |
191 | Ubiquitination | QREAEFTKSIAKFFD HHHHHHHHHHHHHHC | 45.23 | 27667366 | |
191 | Acetylation | QREAEFTKSIAKFFD HHHHHHHHHHHHHHC | 45.23 | 19608861 | |
192 | Phosphorylation | REAEFTKSIAKFFDH HHHHHHHHHHHHHCC | 25.40 | 24719451 | |
195 | Ubiquitination | EFTKSIAKFFDHSGT HHHHHHHHHHCCCCC | 44.91 | 21963094 | |
195 | Acetylation | EFTKSIAKFFDHSGT HHHHHHHHHHCCCCC | 44.91 | 25953088 | |
200 | Phosphorylation | IAKFFDHSGTLVMDA HHHHHCCCCCEEEEC | 35.00 | 28348404 | |
202 | Phosphorylation | KFFDHSGTLVMDAYE HHHCCCCCEEEECCC | 21.13 | 28348404 | |
208 | Phosphorylation | GTLVMDAYEPEISRL CCEEEECCCHHHHHH | 27.96 | - | |
218 | Phosphorylation | EISRLHDSLAIERKI HHHHHHHHHHHHHCC | 14.67 | 29214152 | |
224 | Ubiquitination | DSLAIERKIK----- HHHHHHHCCC----- | 41.90 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SPCS2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SPCS2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SPCS2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TM14C_HUMAN | TMEM14C | physical | 22939629 | |
TM9S4_HUMAN | TM9SF4 | physical | 22939629 | |
TGO1_HUMAN | MIA3 | physical | 26186194 | |
SPCS1_HUMAN | SPCS1 | physical | 26186194 | |
SC11C_HUMAN | SEC11C | physical | 26186194 | |
TM87A_HUMAN | TMEM87A | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-169 AND LYS-191, AND MASSSPECTROMETRY. |